Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,34599,136,1.79 [1.22-2.61],0.0027241564126961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",40144,155,1.49 [1.29-1.72],1.0643024919890361e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,40347,156,2.24 [1.86-2.70],1.8357024047558442e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,34959,138,1.86 [1.23-2.83],0.0034494326018771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,41264,163,2.05 [1.50-2.81],6.36047835874635e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,41389,161,1.30 [1.04-1.63],0.0232006014654227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,40704,155,1.72 [1.02-2.93],0.0436590368001006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,41078,162,1.71 [1.40-2.08],9.478398845329142e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,34599,136,1.55 [1.19-2.02],0.0012259449708234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,41546,162,1.79 [1.28-2.48],0.000569890224966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,40837,159,2.77 [2.12-3.62],6.991116925985415e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,34698,142,1.69 [1.17-2.44],0.005467174668325
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40347,156,2.31 [1.48-3.62],0.0002538244598515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41368,159,2.12 [1.35-3.34],0.0011397541829155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,35570,141,2.83 [1.87-4.27],7.577116892495288e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41580,165,2.44 [1.36-4.38],0.0028590020003805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,35730,144,4.24 [3.04-5.92],2.2541723823421977e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,40704,155,2.42 [1.62-3.60],1.4056713938971178e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,34959,138,2.09 [1.43-3.06],0.0001304306638592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,35570,141,2.19 [1.71-2.79],3.637919478537764e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,41246,167,3.51 [2.29-5.39],8.283427119160919e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,41381,163,3.06 [2.38-3.92],1.936172972939949e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,40885,161,1.77 [1.56-2.00],6.323255257621684e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,40644,155,1.26 [1.02-1.56],0.0347243864634655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,41246,167,2.41 [1.73-3.36],2.359463412239636e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,41078,162,1.60 [1.37-1.86],3.901614371210991e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,41013,162,1.20 [1.02-1.41],0.0294202630340337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,34959,138,0.41 [0.18-0.94],0.0356832169206402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,34769,139,1.50 [1.24-1.80],1.9540197499495934e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,34698,142,1.52 [1.28-1.80],1.5285173560444173e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,41580,165,13.39 [7.53-23.81],1.0172448655367297e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,41086,162,1.64 [1.33-2.03],3.981445526065747e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",35559,140,1.28 [1.01-1.61],0.0378697626267902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",35669,140,1.47 [1.09-1.98],0.0108152103563168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",40885,161,1.17 [1.03-1.34],0.014876064133239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,40885,161,2.63 [1.48-4.67],0.0010014430446618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,40341,157,0.66 [0.49-0.90],0.0081974221129049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,34959,138,1.95 [1.34-2.83],0.0004515912882699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,40968,159,0.54 [0.35-0.84],0.006191041724847
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,41451,161,2.28 [1.65-3.16],7.581362665365578e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,40494,160,2.80 [1.77-4.43],1.0907463714646572e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,41111,167,2.14 [1.55-2.97],4.668705886694308e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,41186,167,1.83 [1.35-2.48],9.7637244319685e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,41451,161,2.05 [1.46-2.88],3.242969059176927e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,41163,162,2.72 [1.82-4.09],1.2800303199139022e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,41229,162,2.30 [1.47-3.59],0.0002571807040184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,35452,143,0.38 [0.25-0.57],3.010855759981643e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,35778,144,0.49 [0.25-0.95],0.0356775415484247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,35749,144,1.50 [1.10-2.04],0.0106626194315442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,35709,144,0.44 [0.28-0.69],0.0003376832697738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,34155,140,0.36 [0.22-0.61],0.0001077169024068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,35749,144,0.45 [0.36-0.57],1.315283572544654e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,35749,144,0.59 [0.43-0.82],0.0016409761862757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,41168,160,0.49 [0.35-0.67],7.523332788454723e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,40885,161,2.25 [1.76-2.87],9.803239860931863e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,41086,162,1.57 [1.18-2.08],0.0018015940579846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,40774,156,1.97 [1.28-3.02],0.0019182923755915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,35725,144,1.78 [1.26-2.51],0.001066119639687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,34599,136,1.33 [1.05-1.69],0.0196281156964024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",34599,136,1.31 [1.06-1.62],0.0119427785659153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,35570,141,1.56 [1.16-2.10],0.0031278809224727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,41229,162,2.27 [1.43-3.61],0.0005319375024247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,35778,144,1.38 [1.02-1.87],0.0374765463131705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",34777,137,1.83 [1.17-2.87],0.0085832707098239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",41246,167,2.38 [1.49-3.80],0.000297675227781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,40144,155,1.71 [1.44-2.03],5.764020542688852e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,41086,162,4.95 [3.37-7.29],4.533552985822149e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",34626,133,0.66 [0.44-0.98],0.0398529301018609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,35080,142,0.47 [0.35-0.65],2.1014882233894885e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,40079,155,1.12 [1.00-1.26],0.0480830331427328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,40704,155,1.49 [1.13-1.97],0.004844650913997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,34959,138,3.24 [2.05-5.11],4.843322470754515e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,41473,162,3.12 [1.63-5.95],0.0005773707399733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,41438,159,2.23 [1.93-2.58],4.840256710089172e-27
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,34474,136,1.26 [1.13-1.42],5.641679872226575e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,41246,167,2.51 [1.58-3.97],9.317377130767506e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,41034,163,1.78 [1.31-2.41],0.0002034623993976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,34474,136,1.38 [1.04-1.82],0.024802931504502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,40116,153,1.37 [1.17-1.61],0.0001199365374864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,34599,136,1.57 [1.06-2.34],0.0250377699102413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,41338,162,2.28 [1.26-4.10],0.0062387633427066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41229,162,2.04 [1.59-2.60],1.3124101641505572e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,34959,138,2.50 [1.62-3.85],3.284505761310529e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,35669,140,1.93 [1.41-2.63],3.6699911316540537e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,35711,144,0.59 [0.35-0.98],0.0420212294219479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,35778,144,0.32 [0.16-0.64],0.0011171824239405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,34922,142,5.36 [3.56-8.08],1.040478704199377e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,35778,144,0.53 [0.32-0.88],0.0143506287814831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,40144,155,1.48 [1.09-2.02],0.0118515927099054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,40885,161,2.00 [1.38-2.91],0.0002783852125697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",40347,156,1.36 [1.18-1.55],1.171025275262316e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,40956,162,0.66 [0.53-0.82],0.000164987744877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,41451,161,2.08 [1.63-2.64],2.227649222620412e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,40697,155,1.29 [1.06-1.58],0.011880782095852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,40949,162,2.98 [1.52-5.86],0.0014960876846149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,40116,153,1.21 [1.01-1.45],0.0365853316733309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,41451,161,1.48 [1.02-2.15],0.0382142923955463
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,34777,137,1.70 [1.35-2.15],6.223167566349424e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,34599,136,0.48 [0.26-0.88],0.0176154927746408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,41078,162,1.59 [1.10-2.29],0.0125557208421973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,41580,165,1.91 [1.45-2.51],3.649049304013748e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,41546,162,1.30 [1.15-1.46],2.809515191350003e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,41246,167,1.56 [1.24-1.96],0.0001587743584448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,41546,162,1.47 [1.11-1.95],0.0073766325195915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,41034,163,1.24 [1.05-1.47],0.0117258885242948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,41509,164,2.11 [1.47-3.01],4.2443051693921706e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,41451,161,1.51 [1.09-2.09],0.0131958001217877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,41086,162,1.73 [1.14-2.62],0.0100455369463371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,40239,158,1.69 [1.25-2.29],0.000717917390888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,41229,162,2.41 [1.82-3.19],7.476547556128965e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,40151,158,1.64 [1.14-2.34],0.0069635715482023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,41546,162,1.75 [1.29-2.39],0.0003578659719321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,41546,162,2.08 [1.29-3.37],0.0027544439970257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,41193,165,1.84 [1.36-2.51],9.510350875090744e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,40774,156,2.00 [1.41-2.83],0.0001008026840923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,41047,167,1.78 [1.21-2.61],0.0032690840431259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,40144,155,1.95 [1.54-2.47],3.560461970484987e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,41438,159,2.28 [1.58-3.28],1.1054636849548118e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,41451,161,1.49 [1.16-1.93],0.0021370303084191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,40885,161,2.20 [1.48-3.28],9.77102246781088e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,41193,165,1.22 [1.01-1.46],0.0351785382970653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,40960,163,1.53 [1.08-2.17],0.0160080684603534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,41059,166,1.36 [1.05-1.77],0.0205895746963118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,40833,159,1.97 [1.29-3.00],0.0016070840367583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,41186,167,3.70 [2.43-5.65],1.330509079948173e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,41392,161,1.85 [1.26-2.71],0.0016124049622335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,39647,157,1.83 [1.17-2.88],0.0087178821322956
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,40979,167,3.49 [1.60-7.58],0.0016329854809202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,39598,154,1.86 [1.08-3.22],0.0261044901037682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,35592,143,1.77 [1.28-2.45],0.0006119462054154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,34959,138,2.09 [1.50-2.90],1.2409752241044284e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,41438,159,2.95 [2.08-4.20],1.4443823227994242e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,41546,162,2.05 [1.55-2.70],4.553342268379415e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,35725,144,4.18 [2.98-5.86],1.3269372658132583e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,41034,163,2.27 [1.57-3.27],1.2711977829617648e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,35570,141,2.53 [1.52-4.21],0.0003756772367162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,41438,159,1.44 [1.11-1.86],0.006173050205824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,39518,153,2.05 [1.35-3.12],0.0008179599096983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,40774,156,1.85 [1.48-2.32],6.761162157683793e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,39693,155,1.66 [1.28-2.15],0.0001141245213081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,41361,158,1.30 [1.08-1.57],0.0058154582390926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,41078,162,1.50 [1.25-1.80],1.267673599354328e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,41078,162,2.74 [1.91-3.93],4.170053099225718e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,41438,159,1.47 [1.01-2.12],0.042288845195768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,41580,165,2.22 [1.46-3.36],0.0001785086218728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,41078,162,2.81 [2.13-3.72],4.2799493229036854e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,40885,161,1.87 [1.53-2.30],1.2119725178558411e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41128,165,8.14 [4.81-13.80],6.5647722335724986e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,35570,141,0.70 [0.58-0.86],0.0005206692534488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,40144,155,1.41 [1.12-1.78],0.0035447817900666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39605,153,1.38 [1.12-1.71],0.0022598498609658
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,34698,142,1.61 [1.19-2.19],0.0020577464431825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,34599,136,1.45 [1.15-1.84],0.0019413092962488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,41167,162,1.39 [1.20-1.60],7.752721573011303e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,40885,161,1.42 [1.13-1.78],0.0025152950426702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,35519,141,0.68 [0.54-0.87],0.0020773114094258
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,35283,142,0.51 [0.40-0.65],4.111448291929966e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,35778,144,0.44 [0.20-0.98],0.0452238316983161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,35778,144,0.34 [0.16-0.73],0.0057979566199046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,41086,162,1.26 [1.03-1.55],0.0274476188955073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,34769,139,1.46 [1.08-1.96],0.0128474910002428
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,41078,162,1.44 [1.05-1.98],0.024764483639513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",35655,142,1.98 [1.52-2.58],3.356546024718194e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,35559,140,2.00 [1.39-2.88],0.0001894409756508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,40174,157,1.57 [1.36-1.81],9.019901881563055e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,35725,144,0.71 [0.53-0.94],0.0166231762313809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,41186,167,2.72 [1.80-4.10],1.7638854924545575e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,41078,162,1.64 [1.26-2.13],0.0002514249272923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,34769,139,1.36 [1.01-1.83],0.0447257984064139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,41346,161,2.79 [2.03-3.82],1.7277393685189582e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,35730,144,1.32 [1.02-1.72],0.0366450592059967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40919,166,1.30 [1.04-1.61],0.0183910197495903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,41009,161,1.58 [1.18-2.10],0.0018327772054437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,41086,162,1.83 [1.21-2.74],0.0037975445585995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,41438,159,0.86 [0.74-1.00],0.0480408817330004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,34945,142,0.53 [0.32-0.87],0.0127493116764333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,41034,163,0.68 [0.46-0.98],0.0412755356547311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,41034,163,0.59 [0.39-0.90],0.0143535554568316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,34769,139,1.52 [1.14-2.03],0.0047537611882582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,41451,161,2.28 [1.22-4.27],0.0098953755992303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,41546,162,2.56 [2.02-3.26],1.7765185448113282e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,35655,142,2.54 [1.74-3.69],1.28471171044666e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,35778,144,0.34 [0.13-0.87],0.0250129842249094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,41229,162,0.51 [0.40-0.65],6.774256170463654e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,40347,156,0.70 [0.52-0.96],0.0246760215303994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,41451,161,1.64 [1.22-2.21],0.0011776499437185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,41086,162,2.09 [1.18-3.70],0.0113013649136584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,41172,156,1.59 [1.10-2.31],0.0141143994883708
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,41034,163,2.20 [1.66-2.91],3.4719199667022473e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,41246,162,1.94 [1.08-3.46],0.025840600578516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,41580,165,3.11 [1.87-5.16],1.179599654301763e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,41078,162,3.28 [2.50-4.30],7.365336678047723e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,34959,138,3.01 [2.42-3.73],1.2543295389770248e-23
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,41580,165,2.15 [1.53-3.01],8.432946094984702e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,41047,167,1.82 [1.11-2.99],0.0176543507302535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",34777,137,1.91 [1.56-2.35],6.445308766901479e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,41580,165,1.28 [1.04-1.58],0.0212844653262661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,41298,158,1.23 [1.01-1.51],0.043401139603638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,41580,165,1.33 [1.08-1.65],0.0077309517542068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,35709,144,0.55 [0.35-0.88],0.0116098539993539
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,41241,155,2.19 [1.50-3.20],5.030946176231303e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,41388,161,2.03 [1.42-2.90],0.0001022458748524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,35725,144,1.83 [1.12-3.00],0.0166664226244596
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,35611,143,3.08 [2.05-4.63],6.84679185849363e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,41229,162,1.85 [1.39-2.46],2.194887275242892e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,40539,163,1.98 [1.46-2.68],1.0500331149911111e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,34959,138,1.72 [1.12-2.64],0.0136111109944415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,41246,167,8.54 [5.09-14.35],5.204178517709242e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,35415,144,0.47 [0.27-0.82],0.0081318190727611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,41580,165,0.63 [0.41-0.96],0.0338585863957432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,40774,156,1.62 [1.23-2.13],0.0006280066262415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,41246,167,3.47 [2.22-5.43],5.030302520679543e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,35749,144,2.55 [1.91-3.41],2.867462329044241e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40774,156,1.29 [1.04-1.59],0.0183309236515662
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,35730,144,2.10 [1.31-3.38],0.0021199652311118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,41161,162,1.60 [1.00-2.54],0.0479932463064149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,40514,160,1.41 [1.03-1.94],0.0316500110366778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,41056,167,1.26 [1.02-1.54],0.0308441415054846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,41102,162,1.57 [1.23-2.00],0.0002690893430358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,40977,166,1.43 [1.07-1.91],0.0151946142504984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,38371,152,2.31 [1.89-2.84],9.033823171573656e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,41078,162,2.99 [1.78-5.01],3.1880609478472993e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,41546,162,2.42 [1.63-3.58],1.0456084828647222e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,32317,114,2.57 [1.25-5.30],0.0106083803569413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,41092,162,2.85 [1.90-4.28],4.17896677870591e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,41034,163,2.01 [1.63-2.49],1.1718765210213163e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,41246,167,1.26 [1.05-1.51],0.0140372114319773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,41438,159,1.24 [1.07-1.44],0.0040573766410456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,41438,159,1.25 [1.06-1.48],0.0098526051587575
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,40795,160,1.54 [1.37-1.74],5.632535588858907e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,41246,167,1.40 [1.05-1.86],0.0232894181991735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,34698,142,1.25 [1.00-1.56],0.0452882193032013
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",40697,155,0.82 [0.67-0.99],0.0385008327235107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,35687,144,0.86 [0.76-0.97],0.0173660253089301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,41078,162,2.10 [1.37-3.22],0.0007016021960227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,41193,165,1.46 [1.15-1.85],0.0016845237056762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40885,161,1.43 [1.07-1.91],0.0162513492246025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,41022,160,1.43 [1.08-1.89],0.0132497433447123
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,41438,159,5.47 [3.51-8.53],6.105716354467683e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,35730,144,1.42 [1.00-2.01],0.0475039722355052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,34698,142,1.75 [1.07-2.88],0.026386324492725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,40144,155,1.26 [1.03-1.55],0.0260806727727093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,34626,133,1.38 [1.05-1.80],0.02026751484567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,34959,138,2.04 [1.34-3.13],0.0009787901322392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,41580,165,3.12 [2.00-4.85],4.446681889338166e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,40710,156,1.41 [1.06-1.88],0.017064327299286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,40885,161,1.34 [1.11-1.62],0.0022548700513907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,41193,165,2.81 [1.86-4.24],8.292602195423911e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,35655,142,1.44 [1.08-1.90],0.0115590099920246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,41034,163,3.13 [2.49-3.95],3.143026321226611e-22
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,40309,157,2.10 [1.31-3.35],0.0019352836014075
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,40885,161,1.78 [1.20-2.65],0.0039926569612177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,40750,161,1.35 [1.07-1.69],0.0099020587563187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,41580,165,2.29 [1.29-4.06],0.0046030419874759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,41327,161,1.33 [1.08-1.63],0.0063258315520404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,40774,156,1.45 [1.05-2.01],0.0230669259039836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,40611,161,2.46 [1.79-3.37],2.6743687521820547e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,35669,140,1.94 [1.26-2.98],0.0026447584919058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,35493,140,1.76 [1.29-2.41],0.0004135293980007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,40885,161,1.86 [1.08-3.19],0.0242054826708133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,41389,161,2.37 [1.56-3.59],4.651920356403659e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,40116,153,1.50 [1.08-2.09],0.014724354927783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",35725,144,1.51 [1.27-1.78],2.227067830104512e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",34777,137,1.22 [1.04-1.44],0.0166414969612412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,34626,133,0.58 [0.36-0.91],0.018975921296901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,41451,161,2.57 [1.89-3.50],2.137017347131621e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41160,162,3.01 [2.02-4.49],5.8059817827337184e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,41021,162,1.65 [1.04-2.60],0.033362438386498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,40704,155,2.36 [1.59-3.53],2.387492554191268e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,34769,139,1.26 [1.00-1.58],0.0456083768885647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,35570,141,1.64 [1.04-2.60],0.0343534587683267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,41580,165,0.38 [0.22-0.66],0.0005511183637409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,41034,163,1.29 [1.07-1.55],0.0074203841326277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,40885,161,1.34 [1.11-1.62],0.00234861240593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,32982,135,0.60 [0.44-0.83],0.0016926639143931
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,41580,165,8.48 [4.82-14.91],1.1122762981376937e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41580,165,5.95 [4.06-8.71],4.526248309514181e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39797,157,1.65 [1.40-1.95],2.8050023879739723e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,40144,155,2.10 [1.73-2.55],8.450758020118985e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,34777,137,1.34 [1.05-1.70],0.0183614340347348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,39628,157,2.67 [2.05-3.49],4.486381051372274e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,34959,138,1.91 [1.09-3.34],0.0235556679372698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,41580,165,3.33 [2.10-5.29],3.319365076394062e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,40697,155,1.70 [1.11-2.62],0.0151812143639774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,41034,163,1.19 [1.01-1.41],0.0360750877530616
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41389,161,2.91 [2.01-4.22],1.7213595606398846e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,41193,165,3.48 [2.03-5.97],6.110213333563905e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,41580,165,1.63 [1.09-2.45],0.0184863953148008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,41047,167,2.47 [1.68-3.62],4.06241581999092e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,34698,142,0.64 [0.43-0.95],0.0271534086247276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,35749,144,0.36 [0.23-0.58],2.49519779170948e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,35265,143,0.49 [0.35-0.70],7.624546926645061e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,35592,143,0.52 [0.28-0.94],0.0309925266656439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,35778,144,0.34 [0.17-0.68],0.002429264908508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,41196,161,1.83 [1.11-3.01],0.0170798712045542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,41170,161,0.59 [0.38-0.90],0.0152835917622984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",41047,167,1.35 [1.18-1.53],9.971232193790543e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",41580,165,1.35 [1.04-1.74],0.0225987186283803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,35669,140,1.11 [1.01-1.21],0.0300228841587081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,40885,161,1.83 [1.21-2.74],0.0037910225574063
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,41580,165,2.17 [1.32-3.57],0.0023284826016388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,41451,164,1.70 [1.33-2.15],1.5017773782050636e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,35730,144,3.19 [2.06-4.92],1.6932854269714586e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",41078,162,1.29 [1.08-1.54],0.0040915381427925
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,35725,144,1.74 [1.42-2.13],8.58796710894745e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,41034,163,1.40 [1.06-1.86],0.0187863287552329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,41086,162,1.41 [1.07-1.86],0.0132981052369771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,40890,160,0.47 [0.38-0.59],7.758475523746103e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,41078,162,1.68 [1.26-2.25],0.0004475269522429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,41354,161,1.52 [1.17-1.98],0.0017939006224678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,40341,157,1.43 [1.11-1.85],0.0053554723652191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,41086,162,1.41 [1.11-1.79],0.0043946491752519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,40144,155,1.40 [1.17-1.67],0.0002445599117883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",34599,136,1.28 [1.04-1.56],0.0176292174178982
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,41168,160,0.64 [0.48-0.85],0.0018367474627225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,34698,142,0.62 [0.38-0.99],0.0452661433928356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,41389,161,1.14 [1.02-1.28],0.0201252901616867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,40341,157,1.51 [1.01-2.25],0.0435893011132468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,41193,165,0.50 [0.34-0.74],0.0004626035562447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,35730,144,0.67 [0.48-0.92],0.0129869299091127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,41193,165,7.29 [4.62-11.49],1.2238527846403109e-17
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,35749,144,1.46 [1.14-1.86],0.0022957480012551
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40774,156,1.99 [1.24-3.18],0.004035945344284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,41002,163,1.64 [1.04-2.60],0.0338342669567425
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,41438,159,2.83 [1.81-4.43],4.677971292550207e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,41064,165,1.07 [1.01-1.14],0.0312916747254618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,40642,155,2.50 [1.37-4.55],0.0027194494889445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,34777,137,3.51 [2.06-5.98],4.075118279413221e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,40983,166,3.79 [2.71-5.30],7.245135460685682e-15
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,35589,142,1.32 [1.12-1.56],0.0011264338153181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,34959,138,1.63 [1.30-2.03],1.9841356574673324e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",34996,138,1.29 [1.05-1.58],0.016411379330632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41438,159,2.17 [1.64-2.86],5.30037602505529e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,41246,167,0.78 [0.63-0.97],0.0231919329627653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40885,161,2.40 [1.50-3.84],0.0002677244299178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41451,161,2.40 [1.43-4.01],0.000872000022922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40341,157,1.47 [1.08-2.01],0.014434945603936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,34599,136,1.61 [1.20-2.15],0.0013840329462818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,41312,163,4.33 [2.55-7.34],5.6295356462760215e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,34599,136,0.60 [0.41-0.88],0.0084659985050984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,35589,141,1.39 [1.10-1.75],0.0050791201767637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,34112,132,1.57 [1.23-2.00],0.0002743462815603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40885,161,1.65 [1.11-2.44],0.0127643925598876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,41580,165,2.39 [2.03-2.81],1.4839506965747216e-25
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,40116,153,1.84 [1.35-2.52],0.0001368035609178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,41389,161,1.78 [1.12-2.83],0.0152777916460556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,41021,162,2.39 [1.97-2.90],6.04759596065162e-19
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,40774,156,3.00 [1.90-4.73],2.440747427779969e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,41022,160,1.09 [1.01-1.18],0.029647147004867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,41078,162,0.83 [0.71-0.98],0.0314194317872699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,35669,140,1.51 [1.11-2.06],0.0084056608189974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,34474,136,1.41 [1.11-1.78],0.0049405639779619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,35655,142,2.27 [1.46-3.52],0.0002524646743605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,35570,141,0.84 [0.72-0.98],0.0309712314977537
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,34888,137,1.83 [1.23-2.71],0.0028941480214879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,34698,142,0.55 [0.30-0.99],0.045435596339997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,34866,140,1.55 [1.18-2.03],0.0017508583736069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,41438,159,2.33 [1.51-3.60],0.0001341841081819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",35730,144,1.93 [1.52-2.45],8.256888219721379e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,40898,160,0.63 [0.41-0.97],0.0376970072523106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,40774,156,0.73 [0.57-0.93],0.0129794579952393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,35559,140,1.56 [1.20-2.03],0.0010134059167024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,39970,154,2.22 [1.36-3.64],0.0014525221195121
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,35559,140,1.79 [1.54-2.08],4.51631658501716e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,40889,161,3.87 [2.36-6.35],8.891252608395151e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",40885,161,1.82 [1.53-2.16],1.6950155693030664e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,35612,144,0.48 [0.29-0.78],0.0028971160447732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,41014,162,1.34 [1.15-1.55],0.000128916333245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,40144,155,1.23 [1.04-1.45],0.0152185617413779
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,35066,138,1.23 [1.03-1.46],0.0220103628693909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,41264,163,1.41 [1.15-1.73],0.0011375513944468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,40347,156,1.17 [1.00-1.37],0.0448899180852469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,41451,161,1.33 [1.20-1.47],2.9582967342496783e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,41392,161,2.01 [1.68-2.41],1.6900859487824868e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,41086,162,2.95 [2.13-4.08],7.080631503661554e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,34959,138,4.36 [2.46-7.72],4.534220265341977e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,41546,162,3.78 [2.87-4.96],1.4547499845787448e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,35415,143,0.60 [0.42-0.87],0.0064131130973439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,34599,136,1.44 [1.01-2.06],0.0453919583686234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,35585,142,1.66 [1.39-1.98],2.0294405853103053e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",40905,162,1.72 [1.21-2.45],0.0025956102126784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,40629,159,1.45 [1.10-1.92],0.0090570765585903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,40116,153,1.66 [1.35-2.04],1.690255336986072e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,40569,153,1.72 [1.30-2.27],0.0001411833930291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,40144,155,0.66 [0.45-0.98],0.0383753268205461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41451,161,1.49 [1.08-2.04],0.0142151718666822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40768,158,2.19 [1.40-3.44],0.0006296361794865
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",41193,165,1.26 [1.02-1.57],0.0351186731618921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,40839,161,2.22 [1.30-3.81],0.0035853211330053
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,40903,159,3.85 [2.70-5.50],1.2155680861695194e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,41580,165,2.11 [1.37-3.27],0.0007495255245915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,41580,165,2.82 [1.70-4.66],5.455032328495496e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,41078,162,1.61 [1.18-2.19],0.002438905594171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",34777,137,1.30 [1.03-1.64],0.0250427932768423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,41451,161,1.40 [1.03-1.90],0.0314687069300015
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,34725,139,2.16 [1.53-3.06],1.2326409312402472e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,41246,167,3.14 [2.04-4.83],1.7360602415606689e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,40774,156,1.38 [1.07-1.78],0.0135872428854369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,40116,153,1.80 [1.40-2.31],3.606781410592608e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,40885,161,1.82 [1.14-2.91],0.012647251942282
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,41515,164,1.14 [1.02-1.28],0.023051270931772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,41229,162,0.39 [0.30-0.51],6.6804617068107416e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,40563,157,1.53 [1.15-2.03],0.0034592638735947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,41580,165,3.34 [2.81-3.97],2.1487455376812282e-42
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,41078,162,3.27 [2.39-4.46],9.524033945421649e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,40885,161,3.30 [2.65-4.11],1.7866817879073366e-26
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,41078,162,1.95 [1.31-2.90],0.0010689867744709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,35725,144,1.37 [1.15-1.63],0.0004134606718535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,41246,167,2.61 [1.95-3.48],6.973981220404248e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,40885,161,1.38 [1.17-1.63],0.0001613855034898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,41546,162,1.58 [1.23-2.02],0.0003263859247128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,40554,164,2.15 [1.18-3.92],0.0125248463714603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,41034,163,1.63 [1.10-2.42],0.0144482813623566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,41086,162,1.43 [1.05-1.95],0.023737278120378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,41229,162,3.49 [2.50-4.89],2.7989813174423535e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,41546,162,2.98 [2.03-4.38],2.911868156248809e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,40046,155,1.29 [1.09-1.54],0.0039533383806978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,41021,162,4.29 [2.76-6.68],1.0705255543362951e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,40988,166,3.40 [1.69-6.83],0.0005865387260211
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,41086,162,0.60 [0.43-0.83],0.0023968673471397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,41451,164,2.20 [1.63-2.96],2.665413126615953e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,40981,166,1.53 [1.26-1.86],2.1380183635882693e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,34346,136,0.60 [0.38-0.96],0.03330244432364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,40793,163,2.18 [1.62-2.94],2.567099449448504e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,41034,163,2.10 [1.68-2.63],5.3064932630446715e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,40341,157,1.55 [1.02-2.35],0.0387842245729284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,40341,157,0.87 [0.77-0.98],0.0213175133768672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,41034,163,2.82 [2.13-3.73],4.717860376917227e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,41034,163,1.32 [1.04-1.67],0.0242056471074074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,40885,161,1.29 [1.12-1.48],0.0004586493357598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,41078,162,4.66 [2.84-7.65],1.1376261989356278e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,35559,140,1.63 [1.26-2.10],0.0001784548264254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,35559,140,1.29 [1.01-1.64],0.0450665407346841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,41034,163,1.43 [1.01-2.03],0.0431656168844652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,41086,162,5.94 [3.76-9.41],2.7475737126854145e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,41086,162,1.63 [1.07-2.47],0.0221877593507719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,35066,138,1.29 [1.00-1.66],0.0499901287156352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,41034,160,2.79 [1.67-4.64],8.108583835649021e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,40838,159,3.09 [2.14-4.48],2.2764892503031923e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,41451,161,1.92 [1.48-2.49],1.091955103867137e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,35730,144,4.09 [3.22-5.18],3.8054903103152e-31
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,35778,144,0.38 [0.16-0.87],0.0227219355021121
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41229,162,1.54 [1.07-2.23],0.0217805733233919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,35778,144,0.49 [0.25-0.96],0.038783703254919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,34474,136,0.52 [0.32-0.84],0.0072892108859011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,41438,159,2.16 [1.35-3.46],0.0013755615756068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,40341,157,1.35 [1.07-1.69],0.0099395254740648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40885,161,1.74 [1.25-2.42],0.0009834425995278
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,34769,139,1.19 [1.00-1.42],0.0483731578126852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,34978,141,1.64 [1.29-2.09],6.627445970115934e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,41193,165,0.45 [0.28-0.72],0.0009874985151096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,40116,153,2.03 [1.38-3.00],0.00035542539016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,34474,136,0.72 [0.52-1.00],0.049350858524906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,34777,137,1.37 [1.06-1.78],0.0163685627205555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,34474,136,1.20 [1.05-1.39],0.0097180239602618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,40116,153,1.62 [1.22-2.14],0.00075689099602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,41078,162,0.40 [0.29-0.56],1.0629972626275796e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,40666,162,1.11 [1.01-1.23],0.0365061768087445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,40149,159,0.57 [0.42-0.78],0.0004082918154104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,34055,134,0.48 [0.31-0.75],0.0013064781446372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,35063,142,0.49 [0.33-0.74],0.0005962001479295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,41546,162,2.00 [1.43-2.81],5.7353909485357175e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",40885,161,1.56 [1.37-1.78],6.630378971079566e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",40970,163,1.49 [1.24-1.79],1.8372196065685463e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",34626,133,1.44 [1.29-1.61],1.29969883885403e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,41546,162,1.40 [1.05-1.87],0.0217346750000147
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,41193,165,2.14 [1.35-3.39],0.001213063425739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,40885,161,2.00 [1.57-2.56],2.598076361327512e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41047,167,1.79 [1.34-2.38],8.152746997256234e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40774,156,1.17 [1.01-1.35],0.0352213228724204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,41246,167,1.60 [1.09-2.35],0.0154257680162883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,34777,137,1.88 [1.09-3.23],0.022376847787639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,40341,157,1.36 [1.05-1.74],0.0181766361883275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,40697,155,2.04 [1.43-2.90],7.525501023572951e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,41229,162,1.43 [1.13-1.80],0.0024821587130489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,35749,144,0.41 [0.28-0.60],3.715577215962883e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,41389,161,1.50 [1.15-1.96],0.0031398456341562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,35778,144,2.49 [1.90-3.26],4.187753905458352e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,41047,167,1.79 [1.44-2.21],1.374562092887179e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,41059,166,2.92 [1.98-4.29],5.7549426864483584e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,40144,155,1.16 [1.01-1.33],0.0326460427216384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,40116,153,1.28 [1.03-1.59],0.0254903016548828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,41034,163,3.59 [2.29-5.63],2.7114125603595494e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41580,165,2.30 [1.40-3.77],0.0009755268835352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41381,163,2.32 [1.53-3.52],8.28239464578107e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,35655,142,2.05 [1.27-3.30],0.0033457981244188
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,39730,153,1.28 [1.01-1.61],0.0383944092095741
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,40885,161,1.72 [1.05-2.82],0.0310119708679858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,40885,161,1.69 [1.27-2.24],0.0002667210075341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,35570,141,1.46 [1.01-2.13],0.0443965779160671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,34769,139,0.59 [0.41-0.87],0.0067062570555143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,41034,163,1.56 [1.15-2.13],0.0048067871062082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,35559,140,1.49 [1.11-2.01],0.0086986950291236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,41580,165,4.84 [3.45-6.77],4.296088308207163e-20
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,40144,155,1.41 [1.14-1.73],0.0014334861622863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,40852,166,3.07 [2.07-4.56],2.565668240427656e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,41034,163,2.14 [1.46-3.13],8.841088591252763e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,40626,156,3.20 [2.02-5.06],6.518754792690641e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,40774,156,1.71 [1.22-2.40],0.0018399044835255
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,40144,155,1.39 [1.12-1.73],0.0029696462944498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,34474,136,0.58 [0.35-0.98],0.0426164644955697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40632,155,1.36 [1.11-1.66],0.0032621025448862
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,35725,144,2.07 [1.36-3.14],0.0006766093861728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",34777,137,1.98 [1.03-3.79],0.0396085896577059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,35725,144,1.34 [1.03-1.76],0.0316260580558049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,34474,136,1.45 [1.10-1.90],0.0078468369090523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,41078,162,2.08 [1.22-3.54],0.0071138730927222
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,41119,167,2.55 [1.62-3.99],4.576964592478593e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,41229,162,1.58 [1.07-2.33],0.0217991125622038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40774,156,1.34 [1.09-1.65],0.0048981871598309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,41451,164,2.30 [1.30-4.09],0.0044658228075861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,34959,138,0.31 [0.20-0.48],1.356942549204758e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,41546,162,2.30 [1.36-3.87],0.0018466116812226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,34959,138,3.23 [2.01-5.20],1.3896356105549546e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,41086,162,1.37 [1.02-1.86],0.0385280212009415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41034,163,1.13 [1.01-1.27],0.0322577892545716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,40341,157,1.59 [1.22-2.06],0.0005017048446737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,41034,163,0.84 [0.72-0.98],0.027370669882597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,40885,161,1.72 [1.48-2.00],1.839060697204754e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,40992,166,1.45 [1.17-1.80],0.0006139558408279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,41140,160,1.46 [1.14-1.87],0.0024533780297098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,40282,156,2.48 [1.85-3.32],1.2941385139796096e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",34599,136,1.35 [1.02-1.79],0.0378092554799541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41186,167,0.82 [0.69-0.97],0.0189122748376896
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,35749,144,3.39 [2.07-5.57],1.3325659867163593e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",34599,136,0.55 [0.32-0.93],0.0264566140862899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,41438,159,2.43 [1.83-3.22],8.583879552618361e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,35066,138,1.58 [1.28-1.96],2.547117818213812e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,40116,153,2.24 [1.80-2.78],2.983451739282145e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,40341,157,1.29 [1.10-1.52],0.002085049728987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,41179,167,1.36 [1.05-1.75],0.0182830294401703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,41193,165,1.97 [1.21-3.20],0.006316210323681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,41438,159,0.69 [0.48-0.99],0.0420564950598077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,40975,162,1.49 [1.04-2.15],0.0306803255194017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,35570,141,3.55 [2.49-5.06],2.4491973477181724e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,41022,160,2.66 [1.78-4.00],2.2005900082929115e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,41193,165,1.60 [1.08-2.37],0.019894760878976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,34698,142,1.46 [1.01-2.12],0.0454079712742357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,41246,167,2.92 [1.91-4.46],7.105481231369449e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,41546,162,6.87 [4.60-10.27],6.005456929047151e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40341,157,1.36 [1.10-1.68],0.0038695961146416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,35669,140,1.32 [1.04-1.67],0.0225782732819153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,34110,133,1.86 [1.08-3.20],0.0248160356838609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,41119,167,1.97 [1.27-3.06],0.0024707952070012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40774,156,1.20 [1.03-1.40],0.0228092902869558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,41086,162,2.91 [1.76-4.80],2.929109468519308e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",34599,136,1.46 [1.01-2.11],0.0469902476081048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",40116,153,1.31 [1.05-1.64],0.0167066378126291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,41580,165,7.84 [3.59-17.13],2.345642404017653e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,41580,165,3.25 [2.24-4.73],6.20621403779348e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,35130,140,2.12 [1.46-3.06],6.913193364653091e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,41078,162,1.67 [1.14-2.46],0.0089608280835533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,41086,162,2.20 [1.64-2.96],1.2608659213323284e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,35730,144,2.14 [1.33-3.45],0.0017551061989184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,41078,162,2.65 [1.71-4.10],1.296941550565734e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,41305,162,3.32 [2.18-5.05],2.092231433768775e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,41086,162,2.65 [1.79-3.92],1.13293695406144e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,41193,165,1.96 [1.62-2.38],4.549589952364442e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,35669,140,2.20 [1.69-2.87],5.456462920657157e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,40676,160,1.26 [1.01-1.56],0.0368954354966762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,41246,167,1.77 [1.26-2.48],0.0009283374565977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,41119,167,1.97 [1.32-2.94],0.0008803983815157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,41305,162,3.59 [1.95-6.60],4.0338272864151175e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,35655,142,2.31 [1.71-3.10],3.5094362406824365e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,34599,136,1.21 [1.02-1.43],0.0304874057814
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,41368,163,3.72 [2.21-6.27],8.347351449317654e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,41034,163,1.23 [1.02-1.49],0.0331941765012057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,34884,137,1.48 [1.09-2.00],0.011346550475369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,35669,140,2.99 [1.91-4.66],1.4344538453021216e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,41078,162,3.28 [2.40-4.49],1.2002142054919438e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,35570,141,1.98 [1.24-3.16],0.0042070503674685
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,35559,140,1.82 [1.32-2.50],0.0002510074875983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,41386,160,1.65 [1.23-2.22],0.0009353380438171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,41078,162,3.79 [2.58-5.58],1.1492515625920198e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,34474,136,1.30 [1.10-1.54],0.0026346675001457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,34698,142,2.01 [1.56-2.57],4.567455814213077e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,41546,162,2.66 [1.94-3.65],1.051605186626613e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,35322,142,0.54 [0.32-0.91],0.0195438588224044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,40567,156,3.44 [2.51-4.73],1.93994925686614e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41086,162,2.43 [1.60-3.68],3.2169593329743684e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,41086,162,2.06 [1.48-2.87],1.73601908815013e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,41078,162,1.55 [1.19-2.02],0.0010122778472071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,35725,144,4.81 [2.70-8.59],1.0265287889634945e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,41118,167,1.23 [1.01-1.50],0.041245822337067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,40774,156,1.27 [1.00-1.62],0.0488471562872388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,41193,165,4.76 [3.12-7.25],3.9547970065500666e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",40989,162,1.25 [1.01-1.54],0.0445410667282304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,41451,164,1.41 [1.08-1.84],0.0118691727775818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,41086,162,2.08 [1.67-2.59],3.791375763468199e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,40791,166,3.33 [2.16-5.12],4.957998685454753e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,34865,141,0.41 [0.20-0.84],0.0150948251262991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,41034,163,0.84 [0.71-1.00],0.0461360629768708
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,41394,163,5.30 [3.36-8.37],7.541763889111144e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,34698,142,1.66 [1.28-2.14],0.000104951668593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40885,161,1.59 [1.21-2.10],0.0010417438019767
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,34777,137,0.79 [0.62-1.00],0.0473942664187858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,35749,144,0.54 [0.33-0.88],0.0123434995597201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,40347,156,2.25 [1.53-3.31],3.520847398472212e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,41246,167,0.64 [0.48-0.85],0.002611080361333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,40144,155,1.28 [1.06-1.55],0.0110155777115027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,41330,164,2.61 [1.96-3.47],3.8147721203187646e-11
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,35655,142,1.77 [1.36-2.32],2.963089365190868e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,41168,160,0.47 [0.33-0.67],2.3315025292634774e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,35778,144,0.41 [0.23-0.75],0.0035529267072729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,34777,137,1.82 [1.21-2.73],0.0040943079112292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,41229,162,1.37 [1.09-1.71],0.0068429577788254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,34698,142,1.82 [1.41-2.35],3.641126427042738e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,40919,166,1.88 [1.38-2.57],6.633033810659376e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,41451,161,3.32 [2.29-4.80],2.1194818666660022e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,35400,142,1.83 [1.15-2.89],0.0103613833288495
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,35570,141,0.69 [0.50-0.95],0.0240231995382784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,40770,158,2.28 [1.60-3.26],5.838659358413903e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,35725,144,1.20 [1.00-1.44],0.0466223313776997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,40116,153,1.99 [1.41-2.81],8.380999132250116e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,40347,156,1.47 [1.14-1.90],0.003061430884493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,34698,142,1.36 [1.07-1.74],0.0132886697777417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,35730,144,2.68 [1.42-5.08],0.0024235414594943
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,35570,141,2.05 [1.56-2.69],2.8711631765211815e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,35570,141,2.45 [1.51-3.99],0.0003016041594573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,40965,163,2.70 [1.55-4.71],0.0004519547411067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,35725,144,2.03 [1.27-3.23],0.0029351248052937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,39933,153,1.85 [1.52-2.24],4.80680563489737e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,41034,163,1.54 [1.11-2.13],0.008836883740157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,41438,159,2.04 [1.47-2.83],2.008483305353014e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,34599,136,1.19 [1.02-1.39],0.0257191165451267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,41134,163,2.18 [1.33-3.56],0.00202433127266
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,35053,142,1.38 [1.08-1.76],0.0096156822566448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,35669,140,1.73 [1.29-2.32],0.0002711584612738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,40112,153,1.54 [1.18-2.02],0.0015312489512203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,40885,161,1.20 [1.00-1.43],0.0438897942644209
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,40885,161,1.35 [1.07-1.70],0.0104983136177496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,34698,142,1.35 [1.14-1.60],0.000408998860899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,41119,167,1.37 [1.06-1.76],0.0162581886580602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,41086,162,2.02 [1.31-3.11],0.00152882351285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REN,Renin,41078,162,1.24 [1.06-1.44],0.0055074009408995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,34959,138,1.44 [1.07-1.93],0.0157518952491581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,35485,142,1.66 [1.23-2.22],0.0007681394249082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,41395,165,2.38 [1.60-3.55],2.10809954945184e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,34777,137,2.05 [1.36-3.07],0.0005547438288843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,34698,142,0.50 [0.28-0.88],0.0169391175079504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,41119,167,4.83 [3.40-6.85],1.2140629116199813e-18
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,41438,159,3.59 [2.10-6.16],3.3195797648121943e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,34777,137,3.44 [1.39-8.52],0.0076056143333717
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41078,162,1.80 [1.17-2.76],0.0073583495892933
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,40885,161,2.06 [1.31-3.25],0.0017432729407446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,41451,161,1.67 [1.18-2.35],0.0036980055204917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,40762,161,1.34 [1.06-1.68],0.0140341284370402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,40347,156,1.28 [1.03-1.59],0.0256894555939625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,39999,153,2.15 [1.47-3.15],8.614345369949114e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,41438,159,3.66 [2.41-5.54],9.375358989080215e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,41260,160,1.76 [1.17-2.66],0.0069745536926853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,41119,167,1.75 [1.16-2.61],0.006939706580139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,40341,157,1.66 [1.24-2.22],0.0006200996759628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,41330,161,1.73 [1.33-2.26],4.085778646672528e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,40144,155,1.22 [1.05-1.42],0.0109962402447095
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,41078,162,2.41 [1.87-3.10],7.759407198301483e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,41078,162,0.56 [0.42-0.75],7.863317958490647e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,35570,141,1.45 [1.21-1.73],3.917131808823149e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,34959,138,1.71 [1.20-2.42],0.0028454201444069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,34777,137,1.54 [1.12-2.14],0.0086794131374086
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,41580,165,2.02 [1.54-2.64],3.515121082504466e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,35778,144,0.40 [0.20-0.82],0.0117544399884375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,40885,161,1.58 [1.11-2.24],0.01043982087861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,41451,164,4.10 [3.16-5.32],3.716092950517568e-26
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,35582,142,1.79 [1.20-2.69],0.0046125314926955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,41580,165,1.54 [1.09-2.16],0.0133035032884383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,39914,156,1.16 [1.04-1.29],0.0085612201864791
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,35238,143,0.44 [0.24-0.79],0.0062218673079585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,40676,161,1.57 [1.32-1.87],4.680089977865445e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,35709,144,0.38 [0.22-0.67],0.0007604619978805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,35709,144,0.64 [0.45-0.92],0.0146122063938919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,35093,140,0.31 [0.14-0.65],0.0021896562527703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,35709,144,0.55 [0.32-0.96],0.0347241549917321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,34769,139,1.71 [1.10-2.65],0.0180057572020918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,41193,165,2.03 [1.25-3.29],0.004258598962607
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,40885,161,3.78 [2.63-5.43],7.661713491175325e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,35123,142,1.41 [1.10-1.82],0.0072680916633081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,35749,144,1.62 [1.17-2.23],0.0032333906742662
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,34474,136,1.15 [1.01-1.30],0.0313711770998714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,35730,144,2.28 [1.47-3.52],0.0002207158040374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,41128,165,1.35 [1.01-1.81],0.0419997340222894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,41246,167,2.23 [1.68-2.97],3.7277701255203495e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,41034,163,3.05 [2.15-4.31],3.152680084890102e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,41086,162,1.23 [1.06-1.43],0.0061861644452137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,41451,161,2.03 [1.36-3.01],0.0004895132941043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,41078,162,3.25 [2.13-4.95],4.550599984999727e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,34777,137,1.95 [1.37-2.75],0.0001752820311769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,41392,161,1.79 [1.13-2.86],0.0138789512987945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41176,161,1.31 [1.01-1.71],0.0431988740621566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,40979,167,1.77 [1.33-2.35],7.70085681933039e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,34698,142,0.70 [0.52-0.94],0.0181745150492305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,40341,157,1.46 [1.14-1.86],0.0026436157826201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,41034,163,1.50 [1.20-1.88],0.0004183060132965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,40144,155,1.97 [1.51-2.57],5.874172712516494e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,40116,153,1.40 [1.14-1.72],0.0013674740948979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,35066,138,1.21 [1.03-1.41],0.0215414864751663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,41451,161,1.96 [1.34-2.88],0.0005671594563447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,41246,167,1.49 [1.06-2.09],0.02189595432875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,41229,156,1.84 [1.42-2.37],2.6707090698099827e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",41086,162,1.59 [1.16-2.17],0.0034730576161773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,41022,160,1.49 [1.03-2.13],0.0320421948486047
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,41086,162,1.72 [1.30-2.27],0.0001397506037109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,41034,163,1.28 [1.05-1.55],0.0134171386181439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,40955,161,5.48 [4.13-7.27],3.592997926108708e-32
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,41119,167,3.15 [2.30-4.32],1.1771342230050196e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,40895,160,3.56 [2.50-5.07],1.8163283902577944e-12
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,41510,164,2.36 [1.80-3.11],7.08610664766543e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,35725,144,3.85 [2.73-5.43],1.3184176372145916e-14
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41022,160,0.82 [0.73-0.93],0.001728390424131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41229,162,1.50 [1.09-2.07],0.0140945653471225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41580,165,1.82 [1.24-2.66],0.0020418467644465
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,41438,159,1.84 [1.40-2.43],1.407028023103017e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,34698,142,0.72 [0.51-1.00],0.0496827074514489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,41034,163,1.66 [1.41-1.96],7.830979969224335e-10
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",35669,140,1.54 [1.25-1.90],5.325544156979818e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,40347,156,0.66 [0.50-0.88],0.0041238510889049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,41086,162,1.91 [1.29-2.83],0.0012366728565965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,36444,140,2.93 [2.21-3.90],1.2249358202649304e-13
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,35725,144,1.82 [1.27-2.62],0.0012057604812123
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,35725,144,1.86 [1.10-3.14],0.0200747456651233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,41193,165,3.05 [1.68-5.54],0.000248860415818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,40897,159,1.18 [1.00-1.39],0.0466553875317891
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,41186,167,1.54 [1.24-1.91],0.0001006506450719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,41043,162,1.56 [1.22-1.98],0.0003099225035568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,41066,164,1.59 [1.30-1.93],4.592618159552142e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,41034,163,1.41 [1.07-1.84],0.0141797901582056
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,41473,162,2.05 [1.54-2.74],1.0568886786975547e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,40834,159,3.91 [2.51-6.11],1.924633901436973e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,41193,165,2.06 [1.45-2.91],4.909981266659225e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,41086,162,3.67 [2.98-4.52],2.9484448470157523e-34
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,41096,160,1.68 [1.25-2.27],0.0006540002977385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,40347,156,0.57 [0.39-0.83],0.0034295287987083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,41438,159,2.50 [1.59-3.93],7.857394411501603e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,41580,165,1.90 [1.24-2.89],0.0028750306284632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,35066,138,1.51 [1.12-2.03],0.0066429804497319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41229,162,2.00 [1.48-2.69],5.6830241578201285e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,40637,161,4.07 [3.16-5.24],1.187957141795933e-27
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,40952,160,3.21 [1.75-5.87],0.0001595848114876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,34698,142,2.25 [1.35-3.75],0.0018240595983369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,35066,138,2.00 [1.00-4.00],0.049348460009848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,35669,140,1.36 [1.04-1.79],0.0232268113920707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40774,156,2.11 [1.55-2.87],1.6597064333430402e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40774,156,1.41 [1.20-1.65],2.4259034039849884e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41546,162,2.28 [1.69-3.07],7.39136727843985e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41047,167,4.43 [3.08-6.36],8.883117163932782e-16
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41193,165,1.86 [1.31-2.66],0.0006109079596419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41119,167,2.00 [1.46-2.75],1.930369133879423e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41119,167,2.21 [1.48-3.30],0.000106221635531
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,34959,138,1.55 [1.04-2.31],0.0307370577686274
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41451,161,1.53 [1.03-2.29],0.0369832161244965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41086,162,2.68 [1.83-3.91],3.703812768839165e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41086,162,1.71 [1.40-2.09],2.0079918094323581e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41438,159,3.65 [2.35-5.68],8.909566379833544e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41473,162,2.04 [1.47-2.83],2.244228906063952e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40774,156,1.62 [1.33-1.99],2.6940798445655363e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41438,159,1.54 [1.16-2.03],0.002627941658679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40774,156,1.73 [1.28-2.34],0.0003642239996082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,41546,162,0.49 [0.29-0.83],0.0083329973278559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,41034,163,0.61 [0.48-0.76],1.8625387127539026e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,41246,167,1.94 [1.18-3.19],0.0087116160483395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41510,165,2.64 [1.92-3.63],2.224333487583438e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,35730,144,2.68 [1.93-3.73],4.827626810943369e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,40787,166,1.71 [1.35-2.15],6.6955100489045445e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,41047,167,1.41 [1.11-1.80],0.0057680035517101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,34474,136,1.30 [1.05-1.59],0.0149068726332937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,35570,141,1.51 [1.29-1.75],1.4996161958095501e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,35389,143,0.45 [0.30-0.67],7.939753134828854e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,41193,165,2.65 [1.71-4.11],1.2640622584448049e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,41078,162,2.01 [1.23-3.28],0.0053191438878293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,40774,156,2.36 [1.72-3.24],1.0236185562601593e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,35725,144,1.22 [1.04-1.43],0.0172185856454598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,40144,155,1.42 [1.15-1.77],0.0012559871975715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,40347,156,1.61 [1.38-1.87],1.542354214801676e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,41168,160,5.46 [3.84-7.76],3.150431924569957e-21
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,34698,142,2.06 [1.21-3.50],0.0076929731150874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,35559,140,1.41 [1.13-1.75],0.00194562906288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,41030,161,1.62 [1.17-2.23],0.0032900301792178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,40144,155,2.29 [1.59-3.29],8.048733320099961e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,41389,161,1.59 [1.15-2.19],0.0049913745531186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,34474,136,1.18 [1.01-1.39],0.0408343582047455
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,41580,165,1.38 [1.15-1.66],0.0005144991084538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,38976,152,1.74 [1.27-2.38],0.0005181921276636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40644,155,0.56 [0.40-0.79],0.0008429031411341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,40341,157,1.62 [1.07-2.45],0.022736891081907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,41451,161,1.38 [1.13-1.69],0.001558230491931
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,35655,142,2.31 [1.49-3.56],0.0001602546973844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,40347,156,1.54 [1.21-1.96],0.0004310722678453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,35655,142,1.53 [1.13-2.08],0.0064943400288966
